Bank of New York Mellon
BIVI icon

Bank of New York Mellon’s BioVie BIVI Stock Holding History

Bank of New York Mellon’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-160
Closed -$8.43K – 4138
2024
Q1 		$8.43K Sell
160
-3
-2% -$308 ﹤0.01% 4130
2023
Q4 		$20.5K Buy
163
+3
+2% +$901 ﹤0.01% 4236
2023
Q3 		$54.4K Sell
160
-167
-51% -$65.3K ﹤0.01% 4157
2023
Q2 		$141K Buy
327
+118
+56% +$79.5K ﹤0.01% 4044
2023
Q1 		$169K Buy
+209
New +$139K ﹤0.01% 3970

Other funds holding BIVI

ACM
Altium Capital Management New York $42M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of New York Mellon's BIVI Position: Q2 2024 in Review

Bank of New York Mellon sold out of BioVie (BIVI) in Q2 2024, closing a stake of 160 shares — an estimated $8.43K sold.

Bank of New York Mellon first reported a position in BIVI in Q1 2023 and held it in 5 quarters. The position peaked at $169K in Q1 2023. 48 funds tracked by Wall St. Rank hold BIVI as of Q2 2024.

  • Bank of New York Mellon reported no remaining BioVie position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 160 BioVie shares in Q2 2024, an estimated $8.43K.
  • Bank of New York Mellon first reported a position in BioVie in Q1 2023 and held it in 5 quarters.
  • Bank of New York Mellon's BioVie position peaked at $169K in Q1 2023.
  • 48 funds tracked by Wall St. Rank held BioVie as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.